dronabinol has been researched along with Benign Neoplasms in 111 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 36 (32.43) | 18.7374 |
| 1990's | 12 (10.81) | 18.2507 |
| 2000's | 21 (18.92) | 29.6817 |
| 2010's | 20 (18.02) | 24.3611 |
| 2020's | 22 (19.82) | 2.80 |
| Authors | Studies |
|---|---|
| Nahler, G | 1 |
| Cosgrave, JM; Gallagher, WM; O'Reilly, EM; Perry, AS | 1 |
| Good, P; Hardy, J; Lord, S | 1 |
| Avilia, G; Bifulco, M; Coppola, L; Laezza, C; Navarra, G; Pagano, C | 1 |
| Agar, MR; Amgarth-Duff, I; Luckett, T; Razmovski-Naumovski, V | 1 |
| Cai, X; Chen, S; Dong, X; Fang, Z; Kang, T; Li, W; Shen, J; Xiong, X; Yan, C; Yang, H; You, H; Zhang, J; Zhou, P | 1 |
| Charbonneau, LF; De Angelis, C; Marchese, M; Peragine, C; Zhu, C | 1 |
| Brens, J; Korenstein, D; Li, QS; Mao, JJ; Raghunathan, NJ; Vemuri, S | 1 |
| Aprikian, S; Canac-Marquis, M; Kasvis, P; Vigano, A; Vigano, M | 1 |
| Hajjar, ER; Handley, N; Worster, B | 1 |
| Attwood, K; Case, AA; Elibol, J; Hansen, ED; Hyland, A; Mupamombe, CT; Nathan, R; Smith, D | 1 |
| Butcher, BE; Clarke, S; Hall, S; Henson, JD; McLachlan, AJ; Rutolo, D; Vitetta, L | 1 |
| Green, R; Khalil, R; Mohapatra, S; Mohapatra, SS | 1 |
| Alderman, B; Amano, K; Bouleuc, C; Case, AA; Crawford, GB; Davis, M; de Feo, G; Garsed, J; Hui, D; Mukhopadhyay, S; Sbrana, A; Tanco, K; To, J | 1 |
| Kaur, S; Nathani, A; Singh, M | 1 |
| Köstenberger, M; Likar, R; Nahler, G | 1 |
| Chow, N; Chow, R; Im, J; Lock, M; Sodhi, E; Valdez, C; Zhang, D | 1 |
| Bíró, K; Kiss, E; Küronya, Z; Martin, T; Szőnyi, M | 1 |
| Gogna, G; Good, P; Greer, R; Hardy, J; Haywood, A; Martin, J; Yates, P | 1 |
| Kasvis, P; Sevryugin, O; Vigano, A; Vigano, M | 1 |
| Behl, T; Harilal, S; Jose, J; Kumar, R; Mathew, B; Musa, A; Parambi, DGT; Shah, MA; Uddin, MS; Unnikrishnan, MK | 1 |
| Bromberg, HS; Chang, YD; Donovan, KA; Haas, MF; Portman, DG; Rajasekhara, S; Randich, AL; Rashid, S | 1 |
| Fisher, T; Golan, H; Toren, A | 1 |
| Dupuis, LL; Jupp, J; Khanna, M; MacDonald, T; Ning, W; Patel, P; Polito, S; Romanick, M; Sung, L; Vennettilli, A; Wiernikowski, J | 1 |
| Carr, C; Fronk, J; Trieu, S; Vertelney, H | 1 |
| Mendes, A | 1 |
| Alessi-Severini, S; Alkabbani, W; Bolton, JM; Bugden, S; Daeninck, P; Leong, C; Marrie, RA | 1 |
| Kohnz, RA; Nomura, DK | 1 |
| Andradas, C; Blasco-Benito, S; Caffarel, MM; Canela, EI; Fernández-Ruiz, J; Gómez-Cañas, M; Guzmán, M; Irving, AJ; Lluís, C; McCormick, PJ; Medrano, M; Moreno, E; Pazos, MR; Pérez-Gómez, E; Sánchez, C | 1 |
| Kramer, JL | 1 |
| Bugaj, B; Cabała, K; Pypno, D; Waracki, M; Zdrojewicz, Z | 1 |
| Fowler, CJ | 1 |
| Armstrong, JL; Babatunde, F; Corazzari, M; Eleni Anagnostou, M; Hernandez-Tiedra, S; Hill, DS; Lopez-Valero, I; Lorente, M; Lovat, PE; McKee, CS; Redfern, CPF; Velasco, G | 1 |
| Martin, JH; Reuter, SE | 1 |
| Abad, JL; Alonso, A; Antón, Z; Armstrong, J; Boya, P; Casas, J; Dávila, D; Fabriàs, G; García-López, R; García-Taboada, E; Goñi, F; González-Martínez, J; Guzmán, M; Hanada, K; Hernández-Tiedra, S; Jäättelä, M; López-Valero, I; Lorente, M; Lovat, P; McKee, CS; Montes, LR; Nylandsted, J; Salanueva, ÍJ; Salazar-Roa, M; Serrano-Puebla, A; Velasco, G | 1 |
| Maida, V | 1 |
| Gertsch, J; Oesch, S | 1 |
| Boya, P; Carracedo, A; Egia, A; Guzmán, M; Hernández-Tiedra, S; Iovanna, JL; Lorente, M; Salanueva, IJ; Salazar, M; Torres, S; Vázquez, P; Velasco, G | 1 |
| Gullett, N; Johnstone, PA; Kucuk, O; Rossi, P | 1 |
| Burnell-Nugent, M; Fallon, MT; Ganae-Motan, ED; Johnson, JR; Lossignol, D; Potts, R | 1 |
| Baracos, VE; Brisbois, TD; Chasen, M; de Kock, IH; Lamoureux, DC; MacDonald, N; Mirhosseini, M; Watanabe, SM; Wismer, WV | 1 |
| Abrams, DI; Aggarwal, SK; Carter, GT; Earleywine, M; Flanagan, AM; Grinspoon, L | 1 |
| Arnold, RM; Wilner, LS | 2 |
| Brower, V | 1 |
| Allende, S; Fallon, MT; Ganae-Motan, ED; McQuade, R; Portenoy, RK; Shaiova, L; Weinstein, S; Wright, S; Yanagihara, R | 1 |
| Burnell-Nugent, M; Fallon, MT; Johnson, JR; Lossignol, D | 1 |
| Bifulco, M; Di Marzo, V | 1 |
| Friedman, H; Klein, TW; Larsen, K; Lu, L; Newton, C; Nong, L; Perkins, I | 1 |
| Kraft, B; Kress, HG | 1 |
| Guy, GW; Russo, E | 1 |
| Davis, MP; Kirkova, J; Walsh, D | 1 |
| Bari, M; Battista, N; Fezza, F; Gasperi, V; Maccarrone, M | 1 |
| Blázquez, C; Carracedo, A; Egia, A; García, S; Gironella, M; Giroux, V; González-Feria, L; Guzmán, M; Iovanna, JL; Lorente, M; Malicet, C; Piris, MA; Velasco, G; Villuendas, R | 1 |
| Cerny, T; Ernst, G; Ko, YD; Luftner, D; Meissner, W; Possinger, K; Reif, M; Ruhstaller, T; Schnelle, M; Strasser, F | 1 |
| Baranowski, V; Barbato, LM; Carter, FJ; Jhangiani, H; Meiri, E; Vredenburgh, JJ; Yang, HM | 1 |
| Costa, B | 1 |
| Corbo, M; Dolzhykov, M; Ennis, M; Irani, S; Maida, V | 1 |
| Rose, M | 1 |
| Colls, BM | 1 |
| Gabryś, K; Kotlarek-Haus, S; Orzechowska-Juzwenko, K | 1 |
| Buchanan-Davidson, DJ; Earhart, RH | 1 |
| Cohen, S | 1 |
| Bolton, A; de Pemberton, R; Whitehouse, JM; Williams, CJ | 1 |
| Bloome, B; McKernan, JF; Orr, LE | 1 |
| Baker, JJ; Lokey, JL; Price, NA; Winokur, SH | 1 |
| Gunby, P | 1 |
| Davignon, JP | 1 |
| Cato, AE; Cocchetto, DM; Cook, LF | 1 |
| Aapro, MS | 1 |
| Andrysiak, T; Fairbanks, L; Goodnight, J; Jamison, K; Sarna, G; Ungerleider, JT | 1 |
| Joranson, DE; Treffert, DA | 1 |
| Brenner, DE; Burish, TG; Carey, MP | 1 |
| George, M; Kramar, A; Pejovic, MH; Thuaire, M; Wolff, JP | 1 |
| Bordin, LA; Clark, RA; Gralla, RJ; Groshen, S; Kalman, LB; Kelsen, DP; Kris, MG; Tyson, LB | 1 |
| Biran, S; Edelstein, E; Fuks, Z; Gez, E; Lander, N; Mechoulam, R | 1 |
| Cronin, C; Sallan, SE; Zelen, M; Zinberg, NE | 1 |
| Beveridge, RA; Schwartz, RH | 1 |
| Doblin, R; Kleiman, MA | 1 |
| Beal, JA | 1 |
| Deeter, P; Nelson, K; Sheehan, F; Walsh, D | 1 |
| Burstein, S | 1 |
| Schwartz, RH; Voth, EA | 1 |
| Mathre, ML | 1 |
| Goldstein, MS; Williams, FF | 1 |
| Mechoulam, R | 1 |
| Gorter, RW | 1 |
| Chan, P; Huff, J | 1 |
| Baron, M | 1 |
| Reiter, GS | 1 |
| Gorter, R | 2 |
| Jatoi, A; Loprinzi, CL; Novotny, PJ; Sloan, JA; Windschitl, HE; Yamashita, J | 1 |
| Christensen, B; Dakhil, SR; Fitch, TR; Jatoi, A; Kardinal, CG; Krook, JE; Loprinzi, CL; Mailliard, JA; Novotny, PJ; Pundaleeka, S; Sloan, JA; Windschitl, HE | 1 |
| Reynolds, R | 1 |
| Avery, DA; Brunk, SF; Canter, AC; Noyes, R | 1 |
| Gantt, C; Machin, D; Staquet, M | 1 |
| Chester, AB; Dean, JC; Dorr, RT; Einhorn, LH; Furnas, B; Herman, TS; Jones, SE; Leigh, SA; Moon, TE; Nagy, C; Williams, SD | 1 |
| Jarvik, ME | 1 |
| Bedell, SE | 1 |
| Dean, J; Dorr, R; Herman, TS; Jones, SE; Leigh, S; Moon, TE; Salmon, SE | 1 |
| Bhargava, HN | 1 |
| Frei, E; Sallan, SE; Zinberg, NE | 1 |
| Adams, L; Bradley, CJ; Cunningham, D; Forrest, GJ; Harding, M; Hutcheon, AW; Kaye, SB; Kerr, DJ; Sneddon, M; Soukop, M | 1 |
| Citron, ML; Cohen, MH; Fossieck, BE; Franklin, R; Harwood, S; Herman, TS; Krasnow, SH; Vreeland, F | 1 |
| Murakami, M; Ota, K | 1 |
| Roffman, RA | 1 |
36 review(s) available for dronabinol and Benign Neoplasms
| Article | Year |
|---|---|
Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics.
Topics: Animals; Antineoplastic Agents; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Neoplasms; Plant Extracts | 2022 |
Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer?
Topics: Cannabidiol; Cannabinoids; Dronabinol; Humans; Neoplasms; Pharmaceutical Preparations; Pilot Projects | 2022 |
Cannabinoids: Therapeutic Use in Clinical Practice.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Endocannabinoids; Humans; Neoplasms | 2022 |
Efficacy of medicinal cannabis for appetite-related symptoms in people with cancer: A systematic review.
Topics: Analgesics; Appetite; Cannabis; Dronabinol; Humans; Medical Marijuana; Neoplasms | 2022 |
Cannabis Use in Patients With Cancer: A Clinical Review.
Topics: Cannabis; Caregivers; Dronabinol; Humans; Nausea; Neoplasms | 2022 |
Role of Cannabidiol for Improvement of the Quality of Life in Cancer Patients: Potential and Challenges.
Topics: Animals; Cannabidiol; Dronabinol; Mice; Neoplasms; Pain; Quality of Life | 2022 |
Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer.
Topics: Adult; Anorexia; Antiemetics; Antineoplastic Agents; Cachexia; Cannabinoids; Cannabis; Consensus; Dronabinol; Expert Testimony; Humans; Nausea; Neoplasms; Randomized Controlled Trials as Topic; Vomiting | 2022 |
Exosomal delivery of cannabinoids against cancer.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Humans; Neoplasms | 2023 |
[Cannabidiol in cancer treatment].
Topics: Animals; Anxiety; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Neoplasms | 2020 |
Oral cannabinoid for the prophylaxis of chemotherapy-induced nausea and vomiting-a systematic review and meta-analysis.
Topics: Adult; Antiemetics; Antineoplastic Agents; Cannabinoids; Dronabinol; Humans; Induction Chemotherapy; Nausea; Neoplasms; Receptor, Cannabinoid, CB2; Vomiting | 2020 |
Taste and smell disturbances in cancer patients: a scoping review of available treatments.
Topics: Adult; Amifostine; Carnosine; Dronabinol; Humans; Neoplasms; Nutritional Status; Olfaction Disorders; Organometallic Compounds; Palliative Care; Quality of Life; Selenium; Smell; Taste; Taste Disorders; Zinc Compounds | 2021 |
An Agathokakological Tale of Δ
Topics: Apoptosis; Cannabis; Cardiovascular Diseases; Cell Cycle; Cell Proliferation; Dronabinol; Humans; Neoplasms; Neurodegenerative Diseases | 2021 |
Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids.
Topics: Animals; Arachidonic Acids; Dronabinol; Eicosanoids; Endocannabinoids; Enzyme Inhibitors; Glycerides; Humans; Lipoprotein Lipase; Monoacylglycerol Lipases; Mood Disorders; Neoplasms; Neurodegenerative Diseases; Pain; Signal Transduction | 2014 |
Medical marijuana for cancer.
Topics: Analgesics, Non-Narcotic; Antiemetics; Canada; Cannabidiol; Clinical Trials as Topic; Dronabinol; Drug Combinations; Evidence-Based Medicine; Humans; Medical Marijuana; Multiple Sclerosis; Neoplasms; Pain; Treatment Outcome; United Kingdom; United States | 2015 |
[Potential applications of marijuana and cannabinoids in medicine].
Topics: Cannabinoids; Diabetes Mellitus; Dronabinol; Humans; Medical Marijuana; Neoplasms; Nervous System Diseases; Pain; Phytotherapy; Receptors, Cannabinoid; Vomiting | 2014 |
Delta(9) -tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature.
Topics: Cannabidiol; Cell Survival; Dronabinol; Humans; Neoplasms; Receptors, Cannabinoid | 2015 |
Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome.
Topics: Anorexia; Cachexia; Cannabidiol; Dronabinol; Humans; Neoplasms; Quality of Life | 2016 |
Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?
Topics: Animals; Antineoplastic Agents; Cannabinoid Receptor Agonists; Cannabinoid Receptor Modulators; Cannabinoids; Dronabinol; Drug Evaluation, Preclinical; Humans; Ligands; Neoplasms; Receptors, Cannabinoid | 2009 |
Cancer-induced cachexia: a guide for the oncologist.
Topics: Acute-Phase Reaction; Anti-Inflammatory Agents, Non-Steroidal; Appetite Stimulants; C-Reactive Protein; Cachexia; Diagnosis, Differential; Dronabinol; Fibrinogen; Humans; Lipolysis; Medical Oncology; Muscle Proteins; Neoplasms; Psychotropic Drugs; Starvation; Syndrome; Tumor Necrosis Factor-alpha | 2009 |
Cannabis in palliative medicine: improving care and reducing opioid-related morbidity.
Topics: Analgesics; Cannabinoids; Dronabinol; Evidence-Based Medicine; Humans; Neoplasms; Pain, Intractable; Palliative Care; Phytotherapy; Quality of Life; Terminally Ill | 2011 |
[The endocannabinoid system as a target for the development of new drugs for cancer therapy].
Topics: Adult; Animals; Antineoplastic Agents; Apoptosis; Cannabinoid Receptor Modulators; Cannabinoids; Cell Death; Disease Models, Animal; Dronabinol; Endocannabinoids; Fatty Acids, Unsaturated; Female; Humans; Male; Mice; Neoplasms; Rats; Receptors, Cannabinoid; Receptors, Drug; Research; Tumor Cells, Cultured | 2003 |
The cannabinoid system and immune modulation.
Topics: Animals; Cannabinoid Receptor Modulators; Cannabinoids; Chemotaxis; Dronabinol; Humans; Immune System; Neoplasms; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Signal Transduction; T-Lymphocytes, Helper-Inducer | 2003 |
[Cannabinoids and the immune system. Of men, mice and cells].
Topics: Animals; Cachexia; Cannabinoids; Dronabinol; HIV Infections; Humans; Immune System; Mice; Neoplasms; Phagocytosis | 2004 |
New insights into endocannabinoid degradation and its therapeutic potential.
Topics: Arachidonic Acid; Arachidonic Acids; Cannabinoid Receptor Agonists; Cannabinoid Receptor Modulators; Cannabis; Cell Membrane; Chemistry, Pharmaceutical; Dronabinol; Endocannabinoids; Glycerides; Humans; Lipoprotein Lipase; Monoacylglycerol Lipases; Neoplasms; Nervous System Diseases; Phosphatidylethanolamines; Phospholipase D; Polyunsaturated Alkamides | 2006 |
On the pharmacological properties of Delta9-tetrahydrocannabinol (THC).
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Dronabinol; Humans; Neoplasms; Neuroprotective Agents; Psychotropic Drugs; Receptors, Cannabinoid | 2007 |
Marijuana research findings: 1980. Therapeutic aspects.
Topics: Animals; Asthma; Cannabis; Dronabinol; Epilepsy; Glaucoma; Humans; Nausea; Neoplasms; Pain | 1980 |
Delta-9-tetrahydrocannabinol: comments on antiemetic trials.
Topics: Antineoplastic Agents; Biological Availability; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Euphoria; Humans; Intestinal Absorption; Nausea; Neoplasms | 1980 |
A critical review of the safety and antiemetic efficacy of delta-9-tetrahydrocannabinol.
Topics: Animals; Antiemetics; Dronabinol; History, 19th Century; History, 20th Century; History, Ancient; Humans; Neoplasms; Vomiting | 1981 |
Prevention of chemotherapy-induced nausea and vomiting in patients with cancer.
Topics: Antiemetics; Antineoplastic Agents; Dronabinol; Humans; Nausea; Neoplasms; Vomiting | 1981 |
Delta-9-tetrahydrocannabinol in cancer chemotherapy: research problems and issues.
Topics: Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Dronabinol; Drug Therapy, Combination; Drug Tolerance; Humans; Nausea; Neoplasms; Research Design | 1983 |
A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia.
Topics: Administration, Oral; Aged; Anorexia; Dronabinol; Female; Humans; Male; Middle Aged; Neoplasms; Patient Satisfaction; Treatment Outcome | 1994 |
Medicinal applications of delta-9-tetrahydrocannabinol and marijuana.
Topics: Appetite Stimulants; Cannabis; Dronabinol; Glaucoma; Humans; Multiple Sclerosis; Muscle Spasticity; Nausea; Neoplasms | 1997 |
Recent advantages in cannabinoid research.
Topics: Acquired Immunodeficiency Syndrome; Antiemetics; Antineoplastic Agents; Appetite Stimulants; Cannabinoids; Dronabinol; Humans; Marijuana Smoking; Neoplasms; Receptors, Cannabinoid; Receptors, Drug; Vomiting | 1999 |
Cancer cachexia and cannabinoids.
Topics: Appetite Stimulants; Cachexia; Cannabinoids; Dronabinol; Humans; Neoplasms; Quality of Life | 1999 |
Management of anorexia-cachexia associated with cancer and HIV infection.
Topics: Anorexia; Antineoplastic Agents; Cachexia; Dronabinol; HIV Infections; Humans; Hydrazines; Megestrol; Megestrol Acetate; Metoclopramide; Neoplasms; Palliative Care | 1991 |
[Recent advances in the management of chemotherapy-induced emesis].
Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Domperidone; Dronabinol; Drug Therapy, Combination; Haloperidol; Humans; Metoclopramide; Nausea; Neoplasms; Prochlorperazine; Vomiting | 1986 |
28 trial(s) available for dronabinol and Benign Neoplasms
| Article | Year |
|---|---|
Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (
Topics: Administration, Oral; Cannabidiol; Double-Blind Method; Dronabinol; Humans; Multicenter Studies as Topic; Neoplasms; Palliative Care; Quality of Life; Queensland; Randomized Controlled Trials as Topic; Syndrome | 2020 |
Safety and efficacy of nabilone for acute chemotherapy-induced vomiting prophylaxis in pediatric patients: A multicenter, retrospective review.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Dronabinol; Female; Humans; Infant; Male; Nausea; Neoplasms; Retrospective Studies; Vomiting | 2018 |
Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain.
Topics: Adult; Aged; Cannabidiol; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Combinations; Endpoint Determination; Female; Humans; Male; Middle Aged; Neoplasms; Pain, Intractable | 2010 |
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial.
Topics: Aged; Double-Blind Method; Dronabinol; Female; Humans; Male; Neoplasms; Olfactory Perception; Palliative Care; Pilot Projects; Placebos; Quality of Life; Taste Perception | 2011 |
Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial.
Topics: Aged; Analgesics, Non-Narcotic; Analgesics, Opioid; Cannabidiol; Chronic Pain; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasms; Pain Measurement; Time Factors | 2012 |
An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics.
Topics: Administration, Oral; Aerosols; Analgesics, Non-Narcotic; Analgesics, Opioid; Belgium; Dose-Response Relationship, Drug; Dronabinol; Drug Tolerance; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Middle Aged; Neoplasms; Pain Measurement; Pain, Intractable; Palliative Care; Terminal Care; Treatment Failure; Treatment Outcome; United Kingdom | 2013 |
Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabi
Topics: Administration, Oral; Adult; Aged; Anorexia; Appetite; Appetite Stimulants; Cachexia; Cannabis; Double-Blind Method; Dronabinol; Female; Germany; Humans; Male; Middle Aged; Neoplasms; Phytotherapy; Plant Extracts; Quality of Life; Treatment Outcome | 2006 |
Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Probability; Reference Values; Risk Assessment; Treatment Outcome; Vomiting | 2007 |
Cannabis and cancer chemotherapy.
Topics: Antiemetics; Clinical Trials as Topic; Dronabinol; Humans; Metoclopramide; Neoplasms; Research Design; Thiethylperazine | 1980 |
A cannabis dilemma.
Topics: Clinical Trials as Topic; Double-Blind Method; Dronabinol; Humans; Neoplasms; Vomiting | 1980 |
Antiemetics for patients treated with antitumor chemotherapy.
Topics: Adolescent; Adult; Aged; Antiemetics; Cisplatin; Cyclizine; Dronabinol; Drug Therapy, Combination; Female; Humans; Male; Metoclopramide; Middle Aged; Nausea; Neoplasms; Pilot Projects; Vomiting | 1980 |
Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis.
Topics: Adult; Aged; Antineoplastic Agents; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Nausea; Neoplasms; Placebos; Prochlorperazine; Vomiting | 1980 |
Delta-9-tetrahydrocannabinol: comments on antiemetic trials.
Topics: Antineoplastic Agents; Biological Availability; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Euphoria; Humans; Intestinal Absorption; Nausea; Neoplasms | 1980 |
Cannabis and cancer chemotherapy: a comparison of oral delta-9-THC and prochlorperazine.
Topics: Adolescent; Adult; Age Factors; Aged; Analysis of Variance; Antineoplastic Agents; Clinical Trials as Topic; Dronabinol; Drug Administration Schedule; Humans; Middle Aged; Nausea; Neoplasms; Prochlorperazine; Random Allocation; Vomiting | 1982 |
Delta-9-tetrahydrocannabinol in cancer chemotherapy: research problems and issues.
Topics: Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Dronabinol; Drug Therapy, Combination; Drug Tolerance; Humans; Nausea; Neoplasms; Research Design | 1983 |
[Randomized comparative trial of a new anti-emetic: nabilone, in cancer patients treated with cisplatin].
Topics: Adolescent; Adult; Aged; Antiemetics; Chlorpromazine; Cisplatin; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Female; Humans; Middle Aged; Nausea; Neoplasms | 1983 |
Antiemetic therapy: a review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol.
Topics: Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Dronabinol; Humans; Metoclopramide; Neoplasms | 1984 |
Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine.
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Child; Clinical Trials as Topic; Dronabinol; Female; Humans; Male; Middle Aged; Neoplasms; Prochlorperazine; Random Allocation | 1980 |
A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia.
Topics: Administration, Oral; Aged; Anorexia; Dronabinol; Female; Humans; Male; Middle Aged; Neoplasms; Patient Satisfaction; Treatment Outcome | 1994 |
Does megestrol acetate down-regulate interleukin-6 in patients with cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group investigation.
Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents, Hormonal; Down-Regulation; Dronabinol; Drug Therapy, Combination; Female; Humans; Interleukin-6; Male; Megestrol Acetate; Middle Aged; Neoplasms; Quality of Life; Treatment Outcome; Weight Loss | 2002 |
Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study.
Topics: Administration, Oral; Aged; Anorexia; Appetite; Double-Blind Method; Dronabinol; Drug Therapy, Combination; Erectile Dysfunction; Female; Humans; Male; Megestrol Acetate; Middle Aged; Neoplasms; Psychotropic Drugs; Quality of Life; Weight Gain | 2002 |
The analgesic properties of delta-9-tetrahydrocannabinol and codeine.
Topics: Analgesics; Aspirin; Cannabis; Clinical Trials as Topic; Codeine; Dextropropoxyphene; Dronabinol; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasms; Pain; Palliative Care; Phytotherapy; Placebos | 1975 |
Effect of a nitrogen analog of tetrahydrocannabinol on cancer pain.
Topics: Analgesics; Clinical Trials as Topic; Codeine; Double-Blind Method; Dronabinol; Humans; Neoplasms; Pain; Secobarbital | 1978 |
Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy.
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Dronabinol; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Prochlorperazine; Vomiting | 1979 |
Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Cannabis; Clinical Trials as Topic; Dronabinol; Female; Humans; Male; Middle Aged; Neoplasms; Phytotherapy; Vomiting | 1975 |
A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues.
Topics: Adolescent; Adult; Aged; Antiemetics; Cisplatin; Clinical Trials as Topic; Dexamethasone; Dronabinol; Drug Therapy, Combination; Female; Humans; Male; Metoclopramide; Middle Aged; Nausea; Neoplasms; Prochlorperazine; Random Allocation; Vomiting | 1988 |
Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting.
Topics: Adult; Aged; Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Humans; Middle Aged; Nausea; Neoplasms; Phenanthridines; Random Allocation; Vomiting | 1985 |
Stress inoculation training in the control of THC toxicities.
Topics: Antineoplastic Agents; Behavior Therapy; Cognition; Dronabinol; Female; Humans; Imagination; Male; Middle Aged; Nausea; Neoplasms; Relaxation Therapy; Stress, Physiological; Vomiting | 1986 |
50 other study(ies) available for dronabinol and Benign Neoplasms
| Article | Year |
|---|---|
Plant-derived cannabinoids as anticancer agents.
Topics: Antineoplastic Agents; Cannabidiol; Cannabinoids; Dronabinol; Humans; Neoplasms | 2022 |
Cannabis suppresses antitumor immunity by inhibiting JAK/STAT signaling in T cells through CNR2.
Topics: Animals; Cannabinoids; Cannabis; Dronabinol; Humans; Immunosuppressive Agents; Janus Kinases; Mice; Neoplasms; Receptor, Cannabinoid, CB2; Signal Transduction; STAT Transcription Factors; T-Lymphocytes | 2022 |
Description and Disposition of Patients With Cancer Accessing a Novel, Pharmacist-Led Cannabis Consultation Service.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Medical Marijuana; Middle Aged; Neoplasms; Pharmacists; Referral and Consultation; Retrospective Studies | 2022 |
In the weeds: a retrospective study of patient interest in and experience with cannabis at a cancer center.
Topics: Analgesics; Cannabinoids; Cannabis; Dronabinol; Drug-Related Side Effects and Adverse Reactions; Humans; Medical Marijuana; Neoplasms; Pain; Retrospective Studies | 2022 |
Sex differences exist in the perceived relief of cancer symptoms with medical cannabis: results from the Quebec Cannabis Registry.
Topics: Analgesics; Cannabidiol; Cannabis; Dronabinol; Fatigue; Female; Humans; Male; Medical Marijuana; Nausea; Neoplasms; Pain; Quebec; Registries | 2022 |
Assessing Efficacy and Use Patterns of Medical Cannabis for Symptom Management in Elderly Cancer Patients.
Topics: Aged; Cannabidiol; Cannabis; Dronabinol; Humans; Medical Marijuana; Nausea; Neoplasms; Pain; Retrospective Studies; Sleep Initiation and Maintenance Disorders | 2023 |
Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain.
Topics: Analgesics; Analgesics, Opioid; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Male; Nanoparticles; Neoplasms; Pain, Intractable; Pilot Projects; Water | 2022 |
Using cannabis in oncology: facts and myths
Topics: Cannabinoids; Cannabis; Dronabinol; Humans; Hungary; Medical Marijuana; Medical Oncology; Neoplasms | 2020 |
Rate of cannabis use in older adults with cancer.
Topics: Aged; Analgesics; Cannabis; Dronabinol; Humans; Neoplasms; Palliative Care; Young Adult | 2022 |
The Role of Cannabinoids in the Treatment of Cancer in Pediatric Patients.
Topics: Cannabinoid Receptor Agonists; Cannabinoids; Child; Dronabinol; Endocannabinoids; Humans; Matrix Metalloproteinase 2; Neoplasms; Palliative Care; Treatment Outcome | 2017 |
Dronabinol for the Treatment of Paraneoplastic Night Sweats in Cancer Patients: A Report of Five Cases.
Topics: Adult; Aged; Dronabinol; Female; Humans; Male; Middle Aged; Neoplasms; Palliative Care; Psychotropic Drugs; Quality of Life; Retrospective Studies; Sleep; Sweating | 2019 |
Developments in medical cannabis.
Topics: Cannabidiol; Community Health Nursing; Dronabinol; Drug and Narcotic Control; Drug Tolerance; England; Health Services Accessibility; Humans; Medical Marijuana; Neoplasms; Pain Management; Patient Preference; State Medicine | 2019 |
Persistence of use of prescribed cannabinoid medicines in Manitoba, Canada: a population-based cohort study.
Topics: Adolescent; Adult; Aged; Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Duration of Therapy; Female; Fibromyalgia; Humans; Male; Manitoba; Medication Adherence; Middle Aged; Neoplasms; Osteoarthritis; Prescription Drugs; Retrospective Studies; Social Class; Substance-Related Disorders; Young Adult | 2019 |
Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling.
Topics: Animals; Breast Neoplasms; Cannabinoids; Cell Line, Tumor; Dronabinol; Female; Gene Targeting; Glioblastoma; HEK293 Cells; Humans; Male; Mice; Mice, Nude; Neoplasms; Protein Structure, Quaternary; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; Recombinant Proteins; RNA, Small Interfering; Signal Transduction; Xenograft Model Antitumor Assays | 2014 |
Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death.
Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cannabidiol; Cannabinoids; Cannabinol; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dacarbazine; Dronabinol; Drug Combinations; Humans; Male; Melanoma; Membrane Proteins; Mice; Mice, Nude; Microscopy, Confocal; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Plant Extracts; Proto-Oncogene Proteins B-raf; ras Proteins; Skin Neoplasms; Temozolomide | 2015 |
Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization.
Topics: Apoptosis; Autophagy; Biological Transport; Cell Line, Tumor; Cell Proliferation; Ceramides; Dronabinol; Endoplasmic Reticulum; Golgi Apparatus; Humans; Intracellular Membranes; Lysosomes; Models, Biological; Neoplasms; Permeability; Phagosomes; Sphingolipids | 2016 |
Nabilone for the treatment of paraneoplastic night sweats: a report of four cases.
Topics: Aged; Aged, 80 and over; Anti-Anxiety Agents; Dronabinol; Female; Humans; Male; Neoplasms; Palliative Care; Paraneoplastic Syndromes; Sleep Deprivation; Sweating | 2008 |
TRB3 links ER stress to autophagy in cannabinoid anti-tumoral action.
Topics: Autophagy; Cannabinoids; Cell Cycle Proteins; Dronabinol; Endoplasmic Reticulum; Humans; Neoplasms; Oxidative Stress; Protein Serine-Threonine Kinases; Repressor Proteins; Signal Transduction | 2009 |
Cannabinoids in the treatment of symptoms in cancer and AIDS, 2nd edition #93.
Topics: Analgesics, Non-Narcotic; Antiemetics; Appetite Stimulants; Cannabinoids; Dronabinol; HIV Infections; Humans; Neoplasms | 2011 |
New pain drugs in pipeline, but challenges to usage remain.
Topics: Analgesics; Analgesics, Opioid; Antineoplastic Agents; Cannabidiol; Cannabinoids; Clinical Trials as Topic; Dronabinol; Drug Combinations; Drugs, Investigational; Humans; Neoplasms; Neuralgia; Pain; Palliative Care; Plant Extracts | 2012 |
A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol.
Topics: Animals; Cannabidiol; Clinical Trials as Topic; Dronabinol; Drug Therapy, Combination; Humans; Neoplasms | 2006 |
The efficacy and tolerability of long-term use of dronabinol in cancer-related anorexia: a case series.
Topics: Aged; Analgesics, Non-Narcotic; Anorexia; Appetite; Dronabinol; Drug Tolerance; Female; Humans; Longitudinal Studies; Male; Middle Aged; Neoplasms; Palliative Care; Treatment Outcome | 2005 |
The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells.
Topics: Activating Transcription Factor 4; Animals; Apoptosis; Basic Helix-Loop-Helix Transcription Factors; Biopsy; Cannabinoids; Cell Cycle Proteins; Dronabinol; Endoplasmic Reticulum; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Mice; Neoplasm Proteins; Neoplasms; Protein Serine-Threonine Kinases; Repressor Proteins; Signal Transduction; Transcription Factor CHOP; Tumor Cells, Cultured; Up-Regulation; Xenograft Model Antitumor Assays | 2006 |
Cannabinoids in the treatment of symptoms in cancer and AIDS #93.
Topics: Acquired Immunodeficiency Syndrome; Anorexia; Antiemetics; Appetite Stimulants; Dronabinol; Humans; Neoplasms | 2006 |
Adjunctive nabilone in cancer pain and symptom management: a prospective observational study using propensity scoring.
Topics: Adjuvants, Pharmaceutic; Aged; Aged, 80 and over; Analgesics; Anti-Anxiety Agents; Antiemetics; Cancer Care Facilities; Dronabinol; Female; Humans; Karnofsky Performance Status; Male; Middle Aged; Neoplasms; Pain Measurement; Pain, Intractable; Palliative Care; Prospective Studies; Treatment Outcome | 2008 |
Cannabis: a medical question?
Topics: Antineoplastic Agents; Dronabinol; Humans; Neoplasms; Vomiting | 1980 |
[Vomiting accompanying cytostatic treatment, and its control].
Topics: Antiemetics; Antineoplastic Agents; Dronabinol; Drug Evaluation; Histamine H1 Antagonists; Humans; Metoclopramide; Neoplasms; Prochlorperazine; Vomiting | 1984 |
Tetrahydrocannabinol as an antiemetic for cancer patients.
Topics: Antiemetics; Dronabinol; Kinetics; Nausea; Neoplasms; Vomiting | 1980 |
Marihuana for nausea and vomiting due to cancer chemotherapy.
Topics: Dronabinol; Drug-Related Side Effects and Adverse Reactions; Humans; Nausea; Neoplasms; Prochlorperazine; Vomiting | 1980 |
Marijuana for nausea and vomiting in cancer patients.
Topics: Antineoplastic Agents; Cannabinoids; Cannabis; Dronabinol; Humans; Nausea; Neoplasms; Vomiting | 1980 |
Many cancer patients receiving THC as antiemetic.
Topics: Antineoplastic Agents; Dronabinol; Humans; Legislation, Drug; Nausea; Neoplasms; United States | 1981 |
Colorado physicians and THC.
Topics: Adolescent; Adult; Aged; Child; Colorado; Confusion; Dronabinol; Humans; Middle Aged; Neoplasms; Physicians | 1981 |
Tetrahydrocannabinol (THC) for cancer patients. A review of the National Cancer Institute program in Wisconsin.
Topics: Dronabinol; Humans; National Institutes of Health (U.S.); Neoplasms; United States; Wisconsin | 1982 |
delta 9-Tetrahydrocannabinol and therapeutic research legislation for cancer patients.
Topics: Antineoplastic Agents; Dronabinol; Humans; Legislation, Drug; National Health Programs; National Institutes of Health (U.S.); Nausea; Neoplasms; United States; United States Food and Drug Administration; Vomiting; Wisconsin | 1983 |
[A marihuana component for nausea and vomiting induced by chemo- and radiotherapy].
Topics: Antiemetics; Antineoplastic Agents; Dronabinol; Humans; Nausea; Neoplasms; Prospective Studies; Vomiting | 1983 |
Marijuana as an antiemetic drug: how useful is it today? Opinions from clinical oncologists.
Topics: Administration, Oral; Adult; Antiemetics; Antineoplastic Agents; Attitude of Health Personnel; Dronabinol; Drug Approval; Humans; Marijuana Smoking; Nausea; Neoplasms; Patient Care Team; Treatment Outcome; Vomiting | 1994 |
The medical use of marijuana: the case for clinical trials.
Topics: Clinical Trials as Topic; Dronabinol; Drug and Narcotic Control; Drug Prescriptions; Humans; Marijuana Smoking; Nausea; Neoplasms; Palliative Care; Treatment Outcome; United States; Vomiting | 1995 |
Appetite effect of dronabinol.
Topics: Acquired Immunodeficiency Syndrome; Anorexia; Appetite; Dronabinol; Humans; Neoplasms; Weight Gain | 1994 |
Marijuana as a medicine.
Topics: Acquired Immunodeficiency Syndrome; Cannabis; Dronabinol; Humans; Neoplasms | 1997 |
Medicinal use of marijuana.
Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Agents; Cannabis; Dronabinol; Humans; Nausea; Neoplasms; Phytotherapy; Vomiting | 1997 |
How we comply with federal guidelines on THC dispensing.
Topics: Cancer Care Facilities; Clinical Trials as Topic; Dronabinol; Drug and Narcotic Control; Hospital Bed Capacity, 500 and over; Hospitals, Special; Humans; National Institutes of Health (U.S.); Neoplasms; Pennsylvania; Pharmacy Service, Hospital; United States | 1981 |
Antitumor effects of THC.
Topics: Animals; Body Weight; Chemoprevention; Dronabinol; Mice; Neoplasms; Psychotropic Drugs; Rats; Survival Analysis | 2000 |
Appetite stimulants: the unsolved truth.
Topics: Aged; Analgesics, Non-Narcotic; Anorexia; Appetite Stimulants; Cachexia; Child; Counseling; Dronabinol; Food Service, Hospital; Humans; Megestrol Acetate; Nausea; Neoplasms; Nutritional Support | 2000 |
The HIV wasting syndrome.
Topics: Adipose Tissue; AIDS-Related Opportunistic Infections; Anabolic Agents; Androgens; Anti-HIV Agents; Dronabinol; Female; HIV Infections; HIV Wasting Syndrome; Humans; Male; Megestrol Acetate; Muscles; Neoplasms; Substance-Related Disorders | 1996 |
Cannabis and cannabidiol: interview with Robert Gorter, M.D. Interview by Fred Gardner.
Topics: Appetite Stimulants; Cachexia; Cannabidiol; Cannabis; Clinical Trials as Topic; Dronabinol; Europe; HIV Infections; Humans; Neoplasms; Phytotherapy; Plant Extracts; United States | 1998 |
Comparative efficacy of dronabinol and megestrol acetate.
Topics: Analgesics, Non-Narcotic; Anorexia; Appetite; Dronabinol; Humans; Legislation, Drug; Megestrol Acetate; Nausea; Neoplasms; Palliative Care; Weight Gain | 2002 |
Necessary risks.
Topics: Animals; Antiemetics; Dogs; Dronabinol; Drug Industry; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant, Newborn; Neoplasms; Pregnancy; Prochlorperazine; Risk; Thalidomide; United States; United States Food and Drug Administration | 1979 |
Cannabis and cancer chemotherapy.
Topics: Antiemetics; Antineoplastic Agents; Dronabinol; Humans; Nausea; Neoplasms; Vomiting | 1979 |
Nabilone: a potent antiemetic cannabinol with minimal euphoria.
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Dronabinol; Euphoria; Female; Humans; Male; Middle Aged; Nausea; Neoplasms | 1977 |
Potential therapeutic applications of naturally occurring and synthetic cannabinoids.
Topics: Alcoholism; Animals; Appetite; Asthma; Cannabinoids; Cough; Depression; Diarrhea; Dronabinol; Epilepsy; Glaucoma; Humans; Hypertension; Narcotics; Neoplasms; Pain; Parasympatholytics; Substance-Related Disorders; Vomiting | 1978 |